Cargando…
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by progressive bone erosion. Leflunomide is originally developed to suppress inflammation via its metabolite A77 1726 to attenuate bone erosion. However, distinctive responsiveness to Leflunomide is observed among RA individu...
Autores principales: | Liang, Chao, Li, Jie, Lu, Cheng, Xie, Duoli, Liu, Jin, Zhong, Chuanxin, Wu, Xiaohao, Dai, Rongchen, Zhang, Huarui, Guan, Daogang, Guo, Baosheng, He, Bing, Li, Fangfei, He, Xiaojuan, Zhang, Wandong, Zhang, Bao-Ting, Zhang, Ge, Lu, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783548/ https://www.ncbi.nlm.nih.gov/pubmed/31594926 http://dx.doi.org/10.1038/s41467-019-12163-z |
Ejemplares similares
-
Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
por: Liang, Chao, et al.
Publicado: (2020) -
Effect of CRP and Kinetics of CRP in Prognosis of Nasopharyngeal Carcinoma
por: Chen, Ruiwan, et al.
Publicado: (2019) -
Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial
por: Zhang, Chi, et al.
Publicado: (2019) -
The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
por: Cheng, Rui, et al.
Publicado: (2023) -
CRP - Part 2
por: BASEC,
Publicado: (2023)